Elon Musk’s brain-chip business Neuralink said on Tuesday that an independent review board has approved the start of recruiting for the first human trial of its brain implant for paralysis sufferers.
Brain-Chip Business Neuralink
It stated those with paralysis due to cervical spinal cord damage or amyotrophic lateral sclerosis.
It may be eligible for the study, but it did not say how many people would be included in the trial, which will last roughly six years.
According to Neuralink, the project will employ a robot to surgically implant a brain-computer interface (BCI) implant.
In a part of the brain that regulates the intention to move, with the initial goal of allowing patients to control a computer cursor or keyboard using only their thoughts.
FDA approval to implant
According to current and former workers, the business, which had planned to get FDA approval to implant its device in 10 patients.
Was negotiating a smaller number of patients with the agency when the agency voiced safety concerns.
Chip Devices Cure illnesses
Elon Musk has lofty goals for Neuralink, claiming that it will allow for faster surgical insertions.
Of the chip devices to cure illnesses such as obesity, autism, depression, and schizophrenia.
In May, the business announced that it had won FDA approval.
For its first-in-human clinical trial, despite the fact that it was already under government inspection for its animal testing practises.
Even if the BCI gadget is found to be safe for human use.
It might take the startup more than a decade to obtain commercial usage certification, according to experts.
To read our blog on “Robots are targeting a new position: stitching blue jeans,” click here